Literature DB >> 24497535

cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner.

W Wei-Lynn Wong1, James E Vince, Najoua Lalaoui, Kate E Lawlor, Diep Chau, Aleksandra Bankovacki, Holly Anderton, Donald Metcalf, Lorraine O'Reilly, Philipp J Jost, James M Murphy, Warren S Alexander, Andreas Strasser, David L Vaux, John Silke.   

Abstract

Loss of inhibitor of apoptosis proteins (IAPs), particularly cIAP1, can promote production of tumor necrosis factor (TNF) and sensitize cancer cell lines to TNF-induced necroptosis by promoting formation of a death-inducing signaling complex containing receptor-interacting serine/threonine-protein kinase (RIPK) 1 and 3. To define the role of IAPs in myelopoiesis, we generated a mouse with cIAP1, cIAP2, and XIAP deleted in the myeloid lineage. Loss of cIAPs and XIAP in the myeloid lineage caused overproduction of many proinflammatory cytokines, resulting in granulocytosis and severe sterile inflammation. In vitro differentiation of macrophages from bone marrow in the absence of cIAPs and XIAP led to detectable levels of TNF and resulted in reduced numbers of mature macrophages. The cytokine production and consequent cell death caused by IAP depletion was attenuated by loss or inhibition of TNF or TNF receptor 1. The loss of RIPK1 or RIPK3, but not the RIPK3 substrate mixed lineage kinase domain-like protein, attenuated TNF secretion and thereby prevented apoptotic cell death and not necrosis. Our results demonstrate that cIAPs and XIAP together restrain RIPK1- and RIPK3-dependent cytokine production in myeloid cells to critically regulate myeloid homeostasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24497535     DOI: 10.1182/blood-2013-06-510743

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  78 in total

1.  Response to Heard et al.

Authors:  Maryline Moulin; Anne K Voss; Tim Thomas; Wendy Wei-Lynn Wong; Wendy D Cook; Frank Koentgen; James Vince; John Silke; David L Vaux
Journal:  EMBO J       Date:  2015-10-01       Impact factor: 11.598

2.  RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.

Authors:  Malek Najjar; Danish Saleh; Matija Zelic; Shoko Nogusa; Saumil Shah; Albert Tai; Joshua N Finger; Apostolos Polykratis; Peter J Gough; John Bertin; Michael Whalen; Manolis Pasparakis; Siddharth Balachandran; Michelle Kelliher; Alexander Poltorak; Alexei Degterev
Journal:  Immunity       Date:  2016-07-05       Impact factor: 31.745

3.  The NuRD chromatin-remodeling complex enzyme CHD4 prevents hypoxia-induced endothelial Ripk3 transcription and murine embryonic vascular rupture.

Authors:  Sarah Colijn; Siqi Gao; Kyle G Ingram; Matthew Menendez; Vijay Muthukumar; Robert Silasi-Mansat; Joanna J Chmielewska; Myron Hinsdale; Florea Lupu; Courtney T Griffin
Journal:  Cell Death Differ       Date:  2019-06-24       Impact factor: 15.828

Review 4.  Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis.

Authors:  Ben A Croker; John Silke; Motti Gerlic
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

5.  When Beauty Is Skin Deep: Regulation of the Wound Response by Caspase-8, RIPK3, and the Inflammasome.

Authors:  James E Vince
Journal:  J Invest Dermatol       Date:  2015-08       Impact factor: 8.551

6.  IAP antagonization promotes inflammatory destruction of vascular endothelium.

Authors:  Axel Witt; Jens M Seeger; Oliver Coutelle; Paola Zigrino; Pia Broxtermann; Maria Andree; Kerstin Brinkmann; Christian Jüngst; Astrid C Schauss; Stephan Schüll; Dirk Wohlleber; Percy A Knolle; Martin Krönke; Cornelia Mauch; Hamid Kashkar
Journal:  EMBO Rep       Date:  2015-03-30       Impact factor: 8.807

Review 7.  Relevance of necroptosis in cancer.

Authors:  Najoua Lalaoui; Gabriela Brumatti
Journal:  Immunol Cell Biol       Date:  2016-12-06       Impact factor: 5.126

Review 8.  Programmed necrosis in the cross talk of cell death and inflammation.

Authors:  Francis Ka-Ming Chan; Nivea Farias Luz; Kenta Moriwaki
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

9.  The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis.

Authors:  Silvia Alvarez-Diaz; Christopher P Dillon; Najoua Lalaoui; Maria C Tanzer; Diego A Rodriguez; Ann Lin; Marion Lebois; Razq Hakem; Emma C Josefsson; Lorraine A O'Reilly; John Silke; Warren S Alexander; Douglas R Green; Andreas Strasser
Journal:  Immunity       Date:  2016-08-11       Impact factor: 31.745

10.  Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity.

Authors:  Maria Raffaella Ambrosio; Giulia De Falco; Bruno Jim Rocca; Aurora Barone; Teresa Amato; Cristiana Bellan; Stefano Lazzi; Lorenzo Leoncini
Journal:  Virchows Arch       Date:  2015-08-19       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.